Moreover, as ADRB2 is essential for ADT-induced neuroendocrine differentiation, the results suggest that high-ADRB2 tumors are more likely to develop aggressive, androgen-indifferent prostate cancers like t-NEPC [125]. This evidence concerns the gene ADRB2 and prostate cancer.